Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
People With Resected SCLC or Large-cell Neuroendocrine Carcinoma, Chemotherapy Is Effective | |
|
| |
People with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were treated with perioperative chemotherapy and surgery had better overall survival outcomes than patients treated with surgery alone concluded research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology.
Small-cell lung cancer (SCLC) represents about 15 percent of lung cancers annually. Of those, about 30 percent of patients have limited disease SCLC. Whereas large-cell neuroendocrine carcinoma (LCNEC) is a subgroup of large-cell carcinoma, that has characteristics similar to SCLC. Surgery in these groups of patients are rare and researchers wanted to know if perioperative chemotherapy would benefit the patients.
The retrospective study looked at 74 patients who underwent lung cancer surgery at the Surgical Centre Marie Lannelongue in Le Plessis Robinson, France between 1979 and 2007. Forty-five patients underwent surgery combined with perioperative chemotherapy and 29 underwent surgery alone. They found, "treatment involving surgery plus perioperative chemotherapy was associated with a significantly longer OS (overall survival) than surgery alone (6.1 years and 2.3 years, respectively)."
The authors point out that there were limitations to their study. Because the data was from 1979, the previous staging system was used. The authors also point out that, "more patients had a node involvement in the chemotherapy group, indicating that physicians may have offered chemotherapy to patients with more advanced disease." However, no conclusion could be made because of the, "small population examined in this study, its retrospective nature, the difference in follow-up between the two groups and the heterogeneity of the combined treatments."
The authors point out that due to the rarity of this population, a prospective trial is unlikely to be feasible and these retrospective data may be of value.
Source-Eurekalert
| |
|
|
More News on: Amoebic Dysentery, Chronic Lymphocytic Leukemia, Hodgkins Lymphoma, Non-Hodgkins Lymphoma, Chemotherapy, Chemotherapy Drugs, Peritoneal Cancer, Rhabdomyosarcoma, Male Breast Cancer
 Comment & Contribute
|
Related Links
Lung Cancer
Lung cancer is the uncontrolled growth of abnormal cells in the lung. Majority of people who get lung cancer have been cigarette smokers, but not all ...
Lung Cancer Screening
Lung cancer accounts for nearly 1.3 million deaths annually worldwide. Lung cancer screening can help in early detection of cancer and possible ...
Risk Factors Associated With Bleeding in Lung Cancer
Massive acute bleeding in the lung, called pulmonary hemorrhage (PH), is a fatal complication seen in lung cancer patients treated with ...
Sirolimus Effective in Treatment of a Rare Type of Lung Cancer (LAM)
What is Lymphangioleiomyomatosis or LAM? Lymphangioleiomyomatosis (LAM) is an rare systemic disease that destroys the lung and ...
Cancer Related News
India Gets Advanced Breast Cancer Detecting Machine
In the national capital, an advanced digital breast cancer detecting machine with the capability to see the lesions in breasts with much more clarity ...
New Method can Help Distinguish Pancreatic Cancer from Pancreatitis
In a promising development that could help improve the accuracy of pancreatic cancer diagnosis, researchers at Mayo Clinic have come up with a new ...
Link Between Agent Orange Exposure and Prostate Cancer
A new study has now linked the exposure to Agent Orange and lethal forms of prostate cancer among the US Veterans. Published early online in ...
Tumour Growth Mechanism Goes a Step Further
New study suggests that loss of a particular tumour-suppressing protein causes abnormal growth of tumours of the brain and nervous system. ...
Link Between Skin Cancer and Lower Risk of Alzheimer's Disease Identified
According to a recent study people who have skin cancer are at a reduced risk of developing Alzheimer's disease. The link does not apply to melanoma, ...
Molecular Profiling Timely for Tailoring Therapy Shown By First Prospective Trial
Patients, and their physicians, are eager to jump into next-era cancer care analysis of an individual's tumor to find and target genetic mutations ...
- Health News Index
- News Quick Links
 |
Chemotherapy
Complete Medindia Resources
|
| News Categories: |
| » | Mediterranean Diet Boosts Ageing Brain Power |
| » | Eating Disorders on the Rise |
| » | 24 Karat Gold Tea Introduced |
| » | Go for the White Veggies as Much as You Go for the Colorful Ones |
| » | Health Benefits of Dark Chocolate Revealed |
| More Diet News | |
|
Ask an Expert
